‘A Disruptive Medical Imaging Device for Cancer Surgery’
TumourVue, a start-up based in Cambridge, aims to develop a potentially transformative medical imaging device for cancer surgery.
Retrospective studies indicate that those undergoing cancer surgery carry a lifelong risk of local reoccurrence of cancer. Therefore, determining clear excision margins during surgery is essential to reducing the risk of reoccurrence.
The TumourVue technology combines an imaging technology and artificial intelligence algorithms to produce more precise visualisation of tumour margins, delivering images in real-time during surgeries. Moreover, unlike conventional imaging tools, this new technology is easy to integrate, and can be worn on a surgeon’s safety or prescription glasses.
The funding from the Medtech Accelerator will be used by the team to develop a working prototype of the device and support clinical validation in partnership with Cambridge University Hospitals NHS Trust.
Gita Khalili Moghaddam and Professor Christopher Lowe
Cambridge University Hospital NHS Foundation Trust & University of Cambridge